We are live on
!
Find out more
GC
Guggenheim Capital Portfolio holdings
AUM
$12.9B
1-Year Est. Return
27.3%
This Fund
S&P 500
This Quarter
Est. Return
+20.76%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$12.9B
AUM Growth
+$2.99B
(+30%)
Cap. Flow
+$1.15B
Cap. Flow
% of AUM
8.87%
Top 10 Holdings %
Top 10 Hldgs %
22.95%
Holding
2,001
New
167
Increased
892
Reduced
787
Closed
133
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$188M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$143M |
| 3 |
Apple
AAPL
|
+$66.1M |
| 4 |
Amazon
AMZN
|
+$65.5M |
| 5 |
Microsoft
MSFT
|
+$63.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CNO Financial Group
CNO
|
+$19.2M |
| 2 |
Gen Digital
GEN
|
+$11.2M |
| 3 |
Reinsurance Group of America
RGA
|
+$10.7M |
| 4 |
RTN
Raytheon Company
RTN
|
+$10.2M |
| 5 |
AES
AES
|
+$8.83M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.71% |
| 2 | Healthcare | 10.09% |
| 3 | Financials | 7.77% |
| 4 | Consumer Discretionary | 7.59% |
| 5 | Communication Services | 6.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Evolent Health
EVH
$447M
| $3.35M | 0.03% |
470,629
| – | – |
|
677
Douglas Emmett
DEI
$1.96B
| $3.33M | 0.03% |
108,694
-92,478
| -46% | -$2.77M |
|
|
BGH
678
Barings Global Short Duration High Yield Fund
BGH
$287M
| $3.33M | 0.03% |
265,044
-5,515
| -2% | -$64K |
|
679
Dycom Industries
DY
$12.3B
| $3.32M | 0.03% |
81,299
-301
| -0.4% | -$10.4K |
|
680
Kennametal
KMT
$2.52B
| $3.31M | 0.03% |
115,416
-20,719
| -15% | -$528K |
|
681
Pool Corp
POOL
$7.5B
| $3.31M | 0.03% |
12,164
+508
| +4% | +$118K |
|
|
UN
682
DELISTED
Unilever NV New York Registry Shares
UN
| $3.3M | 0.03% |
61,982
-5,818
| -9% | -$296K |
|
683
GATX Corp
GATX
$6.27B
| $3.29M | 0.03% |
53,979
+90
| +0.2% | +$5.41K |
|
684
CBRE Group
CBRE
$42.9B
| $3.29M | 0.03% |
72,648
-46,584
| -39% | -$2.01M |
|
|
BXMX
685
DELISTED
Nuveen S&P 500 Buy-Write Income Fund
BXMX
| $3.28M | 0.03% |
298,442
+1,432
| +0.5% | +$15.6K |
|
686
SolarEdge
SEDG
$1.95B
| $3.27M | 0.03% |
23,555
-3,869
| -14% | -$473K |
|
687
Ulta Beauty
ULTA
$24.3B
| $3.27M | 0.03% |
16,048
+3,766
| +31% | +$810K |
|
688
Fortune Brands Innovations
FBIN
$6.06B
| $3.26M | 0.03% |
59,674
-53,050
| -47% | -$2.47M |
|
689
Spire
SR
$4.85B
| $3.25M | 0.03% |
49,409
+37,836
| +327% | +$2.7M |
|
690
Ultragenyx Pharmaceutical
RARE
$2.55B
| $3.25M | 0.03% |
41,493
-7,108
| -15% | -$470K |
|
691
Eaton Vance Tax-Advantaged Dividend Income Fund
EVT
$2.16B
| $3.23M | 0.03% |
168,028
-23,450
| -12% | -$441K |
|
692
Arista Networks
ANET
$238B
| $3.23M | 0.03% |
245,840
+68,464
| +39% | +$926K |
|
693
HP
HPQ
$27.5B
| $3.22M | 0.02% |
184,857
+41,840
| +29% | +$665K |
|
694
Alamos Gold
AGI
$13.9B
| $3.22M | 0.02% |
343,052
-18,952
| -5% | -$146K |
|
|
XLRN
695
DELISTED
Acceleron Pharma
XLRN
| $3.2M | 0.02% |
+33,611
| New | +$3.24M |
|
|
INFO
696
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $3.2M | 0.02% |
42,377
+14,867
| +54% | +$1.01M |
|
|
BLUE
697
DELISTED
bluebird bio
BLUE
| $3.18M | 0.02% |
4,025
+1,409
| +54% | +$1.06M |
|
|
CXO
698
DELISTED
CONCHO RESOURCES INC.
CXO
| $3.17M | 0.02% |
61,605
+38,354
| +165% | +$2.12M |
|
|
GAP
699
The Gap Inc
GAP
$7.37B
| $3.17M | 0.02% |
251,166
+37,616
| +18% | +$339K |
|
700
SBA Communications
SBAC
$19.5B
| $3.17M | 0.02% |
10,635
-15,506
| -59% | -$4.58M |
|
Similar funds
TRSOTSOK
AIM
CII
AAMU
WANY
ACA
ZIG
Guggenheim Capital's Q2 2020 Portfolio in Review
As of Q2 2020, Guggenheim Capital held 2,001 positions worth $12.9B, up 30% from $9.93B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Guggenheim Capital deployed $1.15B of net new capital in Q2 2020, opening 167 new positions and adding to 892 existing holdings. Its largest new stake was SelectQuote: 1,199,960 shares worth $30.4M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was CNO Financial Group, an estimated $19.2M trimmed.
- Guggenheim Capital's largest Q2 2020 buy was SelectQuote: 1,199,960 shares worth $30.4M.
- Guggenheim Capital added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q2 2020, an estimated $188M increase.
- Guggenheim Capital's biggest Q2 2020 reduction was CNO Financial Group, cutting an estimated $19.2M.
- Guggenheim Capital fully exited Raytheon Company in Q2 2020, selling an estimated $10.2M.
- Guggenheim Capital's ten largest holdings make up 23% of its $12.9B portfolio in Q2 2020.
- Guggenheim Capital opened 167 new positions and closed 133 in Q2 2020.
- Guggenheim Capital's portfolio value rose 30% quarter-over-quarter to $12.9B.
Based on Guggenheim Capital's 13F filing for Q2 2020, filed 14 Aug 2020.